Butz A M, Eggleston P, Huss K, Kolodner K, Vargas P, Rand C
School of Medicine, Department of Pediatrics, The Johns Hopkins University, Baltimore, Maryland 21287-3144, USA.
J Asthma. 2001 Oct;38(7):565-73. doi: 10.1081/jas-100107121.
We examined demographic characteristics, patterns of medication use, asthma morbidity, and asthma self-management practices and beliefs among inner-city children currently using a nebulizer. We also describe the relationship between asthma self-management practices and beliefs and anti-inflammatory (AI) therapy. We observed a high rate of morbidity, including frequent emergency room visits, hospitalizations, symptom days and nights, and school absences in this group of school-aged children with asthma. More than three-quarters (81%) reported asthma symptoms consistent with mild persistent or greater severity of asthma, and therefore these subjects should be taking AI medications. Another 16% (36 of 231) of these children reported symptoms consistent with mild intermittent asthma. Only 1 out of 7 children in this study reported taking AI medications. We found that parents of children taking daily AI medications were more likely to agree with the belief that children should use asthma medications daily even when the child is not reporting any symptoms.
我们调查了目前正在使用雾化器的市中心儿童的人口统计学特征、用药模式、哮喘发病率以及哮喘自我管理实践和信念。我们还描述了哮喘自我管理实践和信念与抗炎(AI)治疗之间的关系。我们观察到这组患有哮喘的学龄儿童发病率很高,包括频繁的急诊室就诊、住院、症状发作的白天和夜晚以及缺课情况。超过四分之三(81%)的儿童报告有与轻度持续性或更严重哮喘相符的症状,因此这些受试者应该服用AI药物。另外16%(231名中的36名)的儿童报告有与轻度间歇性哮喘相符的症状。在这项研究中,每7名儿童中只有1名报告服用了AI药物。我们发现,让孩子每天服用AI药物的家长更有可能认同这样的信念,即即使孩子没有报告任何症状,也应该每天使用哮喘药物。